Previous close | 976.60 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 3,692,058 |
Market cap | 8.618B |
Beta (5Y monthly) | 0.51 |
PE ratio (TTM) | 41.07 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.30 (3.10%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
Medical device manufacturer’s policy ultimately passed, making maximum payout for Deepak Nath $11.8m
Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...
This powerhouse FTSE stock has embarked on a new growth strategy that’s already showing good results, but it looks undervalued to me. The post Down 27%, but set for major growth, this hidden FTSE gem looks cheap to me appeared first on The Motley Fool UK.